Variegated RHOA mutations in adult T-cell leukemia/lymphoma

Blood

Volumn 127, Issue 5, 2016, Pages 596-604

  Nagata, Yasunobu ^a   Kontani, Kenji ^a   Enami, Terukazu ^b   Kataoka, Keisuke ^b   Ishii, Ryohei ^c   Totoki, Yasushi ^c   Kataoka, Tatsuki R ^b   Hirata, Masahiro ^b   Aoki, Kazuhiro ^d   Nakano, Kazumi ^d   Kitanaka, Akira ^e   Sakata Yanagimoto, Mamiko ^e   Egami, Sachiko ^e   Shiraishi, Yuichi ^a   Chiba, Kenichi ^b   Tanaka, Hiroko ^a   Shiozawa, Yusuke ^a   Yoshizato, Tetsuichi ^f   Suzuki, Hiromichi ^f   Kon, Ayana ^f   Yoshida, Kenichi ^a   Sato, Yusuke ^g   Sato Otsubo, Aiko ^a   Sanada, Masashi ^b   Munakata, Wataru ^a   Nakamura, Hiromi ^a   Hama, Natsuko ^b   Miyano, Satoru ^a   Nureki, Osamu ^a   Shibata, Tatsuhiro ^a   Haga, Hironori ^a   Shimoda, Kazuya ^a   Katada, Toshiaki ^a   Chiba, Shigeru ^a   Watanabe, Toshiki ^a   Ogawa, Seishi ^a   more..

^a KYOTO UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c UNIVERSITY OF TSUKUBA   (Japan)

^d NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^e KYOTO UNIVERSITY HOSPITAL   (Japan)

^f UNIVERSITY OF MIYAZAKI   (Japan)

^g Laboratory of DNA Information Analysis   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; CD4 ANTIGEN; DNA METHYLTRANSFERASE 3A; GUANOSINE DIPHOSPHATE; GUANOSINE TRIPHOSPHATE; INTERLEUKIN 2 RECEPTOR ALPHA; ISOCITRATE DEHYDROGENASE 2; PROGRAMMED DEATH 1 RECEPTOR; PROTEIN; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; TET2 PROTEIN; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG; RHOA PROTEIN, HUMAN;

ACTIN FILAMENT; ALLELIC IMBALANCE; ARTICLE; BINDING SITE; BIOLOGICAL ACTIVITY; CONTROLLED STUDY; COPY NUMBER VARIATION; DOWN REGULATION; EXON; GAIN OF FUNCTION MUTATION; GENE DELETION; GENE INSERTION; GENE MUTATION; GENE SEQUENCE; GENETIC CODE; HELPER CELL; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KARYOTYPING; LEUKEMOGENESIS; LOSS OF FUNCTION MUTATION; MEMORY T LYMPHOCYTE; PHENOTYPE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; T CELL LEUKEMIA; TRANSCRIPTION INITIATION; ADULT; AMINO ACID SEQUENCE; CHEMICAL STRUCTURE; CHEMISTRY; DNA MUTATIONAL ANALYSIS; GENETICS; HIGH THROUGHPUT SEQUENCING; METABOLISM; MOLECULAR GENETICS; MUTATION; PATHOLOGY; PROTEIN TERTIARY STRUCTURE;

ADULT; AMINO ACID SEQUENCE; BINDING SITES; DNA MUTATIONAL ANALYSIS; GUANOSINE DIPHOSPHATE; GUANOSINE TRIPHOSPHATE; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; LEUKEMIA-LYMPHOMA, ADULT T-CELL; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUTATION; PROTEIN STRUCTURE, TERTIARY; RHOA GTP-BINDING PROTEIN;

EID: 84958083425     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2015-06-644948     Document Type: Article

References (38)

1. Matsuoka M, Jeang KT. Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation. Nat Rev Cancer. 2007;7(4):270-280
2. Sakata-Yanagimoto M, Enami T, Yoshida K, et al. Somatic RHOA mutation in angioimmunoblastic T cell lymphoma. Nat Genet. 2014;46(2):171-175
3. Sakashita A, Hattori T, Miller CW, et al. Mutations of the p53 gene in adult T-cell leukemia. Blood. 1992;79(2):477-480
4. Maeda T, Yamada Y, Moriuchi R, et al. Fas gene mutation in the progression of adult T cell leukemia. J Exp Med. 1999;189(7):1063-1071
5. Hidaka T, Nakahata S, Hatakeyama K, et al. Down-regulation of TCF8 is involved in the leukemogenesis of adult T-cell leukemia/lymphoma. Blood. 2008;112(2):383-393
6. Nakagawa M, Schmitz R, Xiao W, et al. Gain-offunction CCR4 mutations in adult T cell leukemia/lymphoma. J Exp Med. 2014;211(13):2497-2505
7. Totoki Y, Tatsuno K, Yamamoto S, et al. Highresolution characterization of a hepatocellular carcinoma genome. Nat Genet. 2011;43(5):464-469
8. Krzywinski M, Schein J, Birol I, et al. Circos: an information aesthetic for comparative genomics. Genome Res. 2009;19(9):1639-1645
9. Nannya Y, Sanada M, Nakazaki K, et al. A robust algorithm for copy number detection using highdensity oligonucleotide single nucleotide polymorphism genotyping arrays. Cancer Res. 2005;65(14):6071-6079
10. Yamamoto G, Nannya Y, Kato M, et al. Highly sensitive method for genomewide detection of allelic composition in nonpaired, primary tumor specimens by use of affymetrix single-nucleotidepolymorphism genotyping microarrays. Am J Hum Genet. 2007;81(1):114-126
11. Yamaguchi T, Hamanaka S, Kamiya A, et al. Development of an all-in-one inducible lentiviral vector for gene specific analysis of reprogramming. PLoS One. 2012;7(7):e41007
12. Kawazu M, Ueno T, Kontani K, et al. Transforming mutations of RAC guanosine triphosphatases in human cancers. Proc Natl Acad Sci USA. 2013;110(8):3029-3034
13. Tsuruyama T, Okamoto S, Fujimoto Y, et al. Histology of intestinal allografts: lymphocyte apoptosis and phagocytosis of lymphocytic apoptotic bodies are diagnostic findings of acute rejection in addition to crypt apoptosis. Am J Surg Pathol. 2013;37(2):178-184
14. Kataoka TR, Fujimoto M, Moriyoshi K, et al. PD-1 regulates the growth of human mastocytosis cells. Allergol Int. 2013;62(1):99-104
15. Suzuki E, Kataoka TR, Hirata M, et al. Trogocytosis-mediated expression of HER2 on immune cells may be associated with a pathological complete response to trastuzumabbased primary systemic therapy in HER2-overexpressing breast cancer patients. BMC Cancer. 2015;15:39
16. Palomero T, Couronńe L, Khiabanian H, et al. Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas. Nat Genet. 2014;46(2):166-170
17. Yoo HY, Sung MK, Lee SH, et al. A recurrent inactivating mutation in RHOA GTPase in angioimmunoblastic T cell lymphoma. Nat Genet. 2014;46(4):371-375
18. Rohde M, Richter J, Schlesner M, et al; German ICGC MMML-Seq-Project; NHL-BFM Study Group. Recurrent RHOA mutations in pediatric Burkitt lymphoma treated according to the NHLBFM protocols. Genes Chromosomes Cancer. 2014;53(11):911-916
19. Kakiuchi M, Nishizawa T, Ueda H, et al. Recurrent gain-of-function mutations of RHOA in diffusetype gastric carcinoma. Nat Genet. 2014;46(6): 583-587
20. Lawrence MS, Stojanov P, Mermel CH, et al. Discovery and saturation analysis of cancer genes across 21 tumour types. Nature. 2014; 505(7484):495-501
21. Ihara K, Muraguchi S, Kato M, et al. Crystal structure of human RhoA in a dominantly active form complexed with a GTP analogue. J Biol Chem. 1998;273(16):9656-9666
22. Chihara K, Amano M, Nakamura N, et al. Cytoskeletal rearrangements and transcriptional activation of c-fos serum response element by Rho-kinase. J Biol Chem. 1997;272(40): 25121-25127
23. Maesaki R, Ihara K, Shimizu T, Kuroda S, Kaibuchi K, Hakoshima T. The structural basis of Rho effector recognition revealed by the crystal structure of human RhoA complexed with the effector domain of PKN/PRK1. Mol Cell. 1999; 4(5):793-803
24. Lin R, Cerione RA, Manor D. Specific contributions of the small GTPases Rho, Rac, and Cdc42 to Dbl transformation. J Biol Chem. 1999;274(33):23633-23641
25. De Rosa SC, Herzenberg LA, Herzenberg LA, Roederer M. 11-color, 13-parameter flow cytometry: identification of human naive T cells by phenotype, function, and T-cell receptor diversity. Nat Med. 2001;7(2):245-248
26. Boyman O, Sprent J. The role of interleukin-2 during homeostasis and activation of the immune system. Nat Rev Immunol. 2012;12(3):180-190
27. Vukmanovic-Stejic M, Zhang Y, Cook JE, et al. Human CD41 CD25hi Foxp31 regulatory T cells are derived by rapid turnover of memory populations in vivo. J Clin Invest. 2006;116(9): 2423-2433
28. Akbar AN, Vukmanovic-Stejic M, Taams LS, Macallan DC. The dynamic co-evolution of memory and regulatory CD41 T cells in the periphery. Nat Rev Immunol. 2007;7(3):231-237
29. Rufer N, Brummendorf TH, Kolvraa S, et al. Telomere fluorescence measurements in granulocytes and T lymphocyte subsets point to a high turnover of hematopoietic stem cells and memory T cells in early childhood. J Exp Med. 1999;190(2):157-167
30. Yoshida N, Karube K, Utsunomiya A, et al. Molecular characterization of chronic-type adult T-cell leukemia/lymphoma. Cancer Res. 2014; 74(21):6129-6138
31. Sauer S, Bruno L, Hertweck A, et al. T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR. Proc Natl Acad Sci USA. 2008;105(22):7797-7802
32. Morin P, Flors C, Olson MF. Constitutively active RhoA inhibits proliferation by retarding G(1) to S phase cell cycle progression and impairing cytokinesis. Eur J Cell Biol. 2009; 88(9):495-507
33. Takai Y, Sasaki T, Matozaki T. Small GTP-binding proteins. Physiol Rev. 2001;81(1):153-208
34. Garćia-Mata R, Wennerberg K, Arthur WT, Noren NK, Ellerbroek SM, Burridge K. Analysis of activated GAPs and GEFs in cell lysates. Methods Enzymol. 2006;406:425-437
35. Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014;513(7517): 202-209
36. Wang K, Yuen ST, Xu J, et al. Whole-genome sequencing and comprehensive molecular profiling identify new driver mutations in gastric cancer. Nat Genet. 2014;46(6):573-582
37. Radtke F, Raj K. The role of Notch in tumorigenesis: oncogene or tumour suppressor? Nat Rev Cancer. 2003;3(10):756-767
38. Yap DB, Chu J, Berg T, et al. Somatic mutations at EZH2 Y641 act dominantly through a mechanism of selectively altered PRC2 catalytic activity, to increase H3K27 trimethylation. Blood. 2011;117(8):2451-2459.